Stifel Nicolaus analyst Brad Reback maintained a Hold rating on Vertex (VERX – Research Report) today and set a price target of $31.00. The ...

JMP Securities analyst Patrick Walravens maintained a Buy rating on Vertex (VERX – Research Report) today and set a price target of $61.00. The ...

The diabetes market is booming, with continuous glucose monitoring (CGM) and GLP-1 drugs leading the charge in innovation and ...

DelveInsight's "CABLIVI Market Size, Forecast, and Market Insight Report" highlights the details around CABLIVI, a von ...

Google on Tuesday announced new health-care updates to Search. The company said it has expanded knowledge panels to cover "thousands" more health topics, and they will be available in more countries ...

We recently published a list of 13 High Growth Large Cap Stocks To Invest In. In this article, we are going to take a look at ...

Alphabet's Google on Monday expanded its partnership with Reddit amid concerns that the social media platform's user growth ...

Pilgrim, one of Indias fastest-growing beauty and personal care brands, has successfully raised Rs200 crore in a mix of ...

Shares of Vertex Pharmaceuticals have received an average “Moderate Buy” rating from 26 brokerages. Analysts are divided, ...

Goldman Sachs analyst expects positive updates from Vertex's first Investor Day as a public company on March 19, reiterates ...

Woollen rugs that resemble the side profiles of human faces are among 11 new products featured on Dezeen Showroom.